Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of 3D Systems Corporation during the specified Class Period of the upcoming lead plaintiff deadline on August 12, 2025, for a class action lawsuit [1][2]. Group 1: Class Action Details - Investors who bought 3D Systems securities between August 13, 2024, and May 12, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by August 12, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time and being ranked No. 1 for the number of settlements in 2017 [3]. - The firm has recovered hundreds of millions of dollars for investors, securing over $438 million in 2019 alone [3]. Group 3: Case Allegations - The lawsuit alleges that during the Class Period, 3D Systems made false and misleading statements regarding the impact of weakened customer spending and overstated its resilience in challenging industry conditions [4]. - It is claimed that the updated milestone criteria in a partnership with United Therapeutics Corporation would negatively affect 3D Systems' Regenerative Medicine Program revenue, leading to materially false public statements [4].

Core Viewpoint - A class action securities lawsuit has been filed against 3D Systems Corporation, alleging securities fraud that negatively impacted investors between August 13, 2024, and May 12, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [2]. - It is also alleged that updated milestone criteria in the partnership with United Therapeutics Corporation would adversely affect the revenue from the Company's regenerative medicine program [2]. - As a result, the Company's public statements during the relevant period were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 12, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of 3D Systems Corporation during the specified Class Period of the upcoming lead plaintiff deadline on August 12, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - The class action lawsuit against 3D Systems alleges that the company made false and misleading statements regarding its business performance and the impact of customer spending, as well as the revenue from its Regenerative Medicine Program [4]. - Investors who purchased 3D Systems securities between August 13, 2024, and May 12, 2025, may be eligible to join the class action and seek compensation [1][2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [3].

DDD investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and ...

NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. T ...

NEW YORK, July 29, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit. WHAT'S NEXT? If you suffered a loss in 3D Systems Corporation during the relevant time frame, you have until August 12, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class memb ...

Core Viewpoint - 3D Systems has launched its NextDent Jetted Denture Solution, a first-to-market product that offers a faster, cost-effective, and scalable alternative to traditional denture fabrication, enhancing patient experience and providing a strong return on investment for dental labs [1][6][7]. Product Overview - The NextDent Jetted Denture Solution utilizes multiple materials in a single printing process to create durable, aesthetically pleasing monolithic dentures [1][6]. - The solution is based on the NextDent 300 MultiJet 3D printer, which allows for rapid production of patient-specific dentures without the need for post-curing steps [2][3]. - Two specialized FDA-cleared materials, NextDentJet Teeth and NextDent Jet Base, are used to ensure tooth rigidity and gum support while providing excellent aesthetics and toughness [2][3]. Manufacturing Efficiency - The continuous flow print process enables the production of single-piece dentures with significantly reduced lead times and labor costs, achieving production speeds that are up to 300% faster than traditional methods [3][4][9]. - The digital workflow can produce a final product in one day, compared to a five-day turnaround with traditional production methods [4][9]. Market Potential - The U.S. dental market for replacement products is projected to reach $600 million by 2029, with the overall U.S. dental market representing nearly $1 billion when combined with other segments [7][9]. - 3D Systems' NextDent Jetted Denture Solution is positioned as a key component of the company's strategy to address various facets of dentistry, including straightening, protecting, repairing, and replacing teeth [7][9]. Customer Feedback - Beta testing with leading dental labs has yielded positive feedback, highlighting the solution's ease of use, material properties, and efficiency improvements [4][9]. - Customers report significant reductions in fabrication time and labor costs, as well as enhanced patient experiences due to faster service and high-quality materials [9].

Core Viewpoint - A class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made misleading statements regarding its financial health and the impact of customer spending on its business [3][4]. Financial Performance - 3D Systems reported a Q4 non-GAAP loss of $0.19 per share, missing consensus estimates by $0.08 [6] - Q4 revenue was $111 million, representing a 3.4% year-over-year decline and falling short of expectations by $4.17 million [6] - Full-year revenue for 2024 was $440.1 million, a 10% decline year-over-year attributed to lower hardware sales and macroeconomic challenges [6] - The company experienced a $9 million revenue reduction in Q4 due to revised accounting estimates for its Regenerative Medicine Program [6] - In Q1 2025, revenue was $94.5 million, an 8% year-over-year decline, and below the consensus estimate of $99.5 million [6] - The net loss for Q1 2025 was $37 million (or $0.28 per share), more than double the $16 million loss in Q1 2024 [6] - An adjusted loss of $0.21 per share was reported, worse than the expected $0.14 loss [6] - The adjusted EBITDA was negative at $23.9 million, compared to a $20.1 million loss in Q1 2024 [6] Class Action Details - The class action lawsuit covers investors who purchased securities between August 13, 2024, and May 12, 2025 [1] - Investors have until August 12, 2025, to file a lead plaintiff motion [1] - The lawsuit claims that 3D Systems failed to disclose the negative impact of weakened customer spending and changes in its partnership with United Therapeutics Corporation [3]

Core Viewpoint - A class action securities lawsuit has been filed against 3D Systems Corporation, alleging securities fraud that negatively impacted investors between August 13, 2024, and May 12, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [2]. - It is alleged that updated milestone criteria in the partnership with United Therapeutics Corporation would adversely affect the revenue from the Company's regenerative medicine program [2]. - As a result, the Company's public statements during the relevant period were materially false and misleading [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 12, 2025, to request to be appointed as lead plaintiff in the case [3]. - Participation in the lawsuit does not require investors to serve as lead plaintiffs to share in any potential recovery, and there are no out-of-pocket costs or fees for class members [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Points - A shareholder class action lawsuit has been filed against 3D Systems Corporation, alleging that the company made materially false and misleading statements regarding its business and operations [1] - The lawsuit claims that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [1] - Additionally, the updated milestone criteria in the United Partnership are said to negatively impact the revenue of the Company's Regenerative Medicine Program [1] Legal Information - Shareholders who purchased shares of 3D Systems between August 13, 2024, and May 12, 2025, and experienced significant losses are encouraged to discuss their legal rights [2] - The deadline to request to be appointed lead plaintiff in the case is August 12, 2025 [3] - Holzer & Holzer, LLC is a law firm specializing in securities litigation and has a history of recovering significant amounts for shareholders affected by corporate misconduct [3]